Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors
Article in Cancers (March 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy
Article in International Journal of Nanomedicine (March 2024)
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort
Article in Clinical and Experimental Medicine (January 2024)